Silymarin selectively protects human renal cells from cisplatin-induced cell death

References

• Ajith TA, Usha S, Nivitha V. (2007). Ascorbic acid and alpha-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: A comparative study. Clin Chim Acta, 375, 82–86.
   PubMed Web of Science ®Google Scholar
• Andreoli SP. (1991). Reactive oxygen molecules, oxidant injury and renal disease. Pediatr Nephrol, 5, 733–742.
   PubMed Web of Science ®Google Scholar
• Asghar Z, Masood Z. (2008). Evaluation of antioxidant properties of silymarin and its potential to inhibit peroxyl radicals in vitro. Pak J Pharm Sci, 21, 249–254.
   PubMed Web of Science ®Google Scholar
• Atallah E, Flaherty L. (2005). Treatment of metastatic malignant melanoma. Curr Treat Options Oncol, 6, 185–193.
   PubMedGoogle Scholar
• Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. (2003). Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med, 142, 178–186.
   PubMed Web of Science ®Google Scholar
• Bosisio E, Benelli C, Pirola O. (1992). Effect of the flavonolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacol Res, 25, 147–154.
   PubMed Web of Science ®Google Scholar
• Bragado P, Armesilla A, Silva A, Porras A. (2007). Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis, 12, 1733–1742.
   PubMed Web of Science ®Google Scholar
• Deep G, Singh RP, Agarwal C, Kroll DJ, Agarwal R. (2006). Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: A comparison of flavonone silibinin with flavonolignan mixture silymarin. Oncogene, 25, 1053–1069.
   PubMed Web of Science ®Google Scholar
• Djamali A. (2007). Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts. Am J Physiol Renal Physiol, 293, F445–F455.
   PubMed Web of Science ®Google Scholar
• Eastman A. (1987). Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes. Chem Biol Interact, 61, 241–248.
   PubMed Web of Science ®Google Scholar
• Fehér J, Láng I, Nékám K, Csomós G, Müzes G, Deák G. (1987). Effect of silibinin on the activity and expression of superoxide dismutase in lymphocytes from patients with chronic alcoholic liver disease. Free Radic Res Commun, 3, 373–377.
   PubMedGoogle Scholar
• Flora K, Hahn M, Rosen H, Benner K. (1998). Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol, 93, 139–143.
   PubMed Web of Science ®Google Scholar
• Galle J. (2001). Oxidative stress in chronic renal failure. Nephrol Dial Transplant, 16, 2135–2137.
   PubMed Web of Science ®Google Scholar
• Gibellini L, Pinti M, Nasi M, Biasi SD, Roat E, Bertoncelli L, Cossarizza A. (2010). Interfering with ROS metabolism in cancer cells: The potential role of quercetin. Cancers, 2, 1288–1311.
   PubMedGoogle Scholar
• Gutteridge JM. (1984). Lipid peroxidation initiated by superoxide-dependent hydroxyl radicals using complexed iron and hydrogen peroxide. FEBS Lett, 172, 245–249.
   PubMed Web of Science ®Google Scholar
• Huang Q, Wu LJ, Tashiro S, Onodera S, Li LH, Ikejima T. (2005). Silymarin augments human cervical cancer HeLa cell apoptosis via P38/JNK MAPK pathways in serum-free medium. J Asian Nat Prod Res, 7, 701–709.
   PubMed Web of Science ®Google Scholar
• Kelland L. (2007). The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer, 7, 573–584.
   PubMed Web of Science ®Google Scholar
• Launay-Vacher V, Rey JB, Isnard-Bagnis C, Deray G, Daouphars M; European Society of Clinical Pharmacy Special Interest Group on Cancer Care. (2008). Prevention of cisplatin nephrotoxicity: State of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol, 61, 903–909.
   PubMed Web of Science ®Google Scholar
• Mansour HH, Hafez HF, Fahmy NM. (2006). Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol, 39, 656–661.
   PubMedGoogle Scholar
• Matsushima H, Yonemura K, Ohishi K, Hishida A. (1998). The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med, 131, 518–526.
   PubMed Web of Science ®Google Scholar
• Mira L, Silva M, Manso CF. (1994). Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem Pharmacol, 48, 753–759.
   PubMed Web of Science ®Google Scholar
• Miyajima A, Nakashima J, Tachibana M, Nakamura K, Hayakawa M, Murai M. (1999). N-Acetylcysteine modifies cis-dichlorodiammineplatinum-induced effects in bladder cancer cells. Jpn J Cancer Res, 90, 565–570.
   Google Scholar
• Miyajima A, Nakashima J, Yoshioka K, Tachibana M, Tazaki H, Murai M. (1997). Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. Br J Cancer, 76, 206–210.
   PubMed Web of Science ®Google Scholar
• Muriel P, Garciapiña T, Perez-Alvarez V, Mourelle M. (1992). Silymarin protects against paracetamol-induced lipid peroxidation and liver damage. J Appl Toxicol, 12, 439–442.
   PubMed Web of Science ®Google Scholar
• Nath KA, Norby SM. (2000). Reactive oxygen species and acute renal failure. Am J Med, 109, 665–678.
   PubMed Web of Science ®Google Scholar
• Pabla N, Dong Z. (2008). Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int, 73, 994–1007.
   PubMed Web of Science ®Google Scholar
• Patrick JL, Lawrence HE. (1984). Diagnosis and treatment. Drugs five years later. Cisplatin. Ann Intern Med, 100, 704–713.
   Google Scholar
• Reedijk J, Lohman PH. (1985). Cisplatin: Synthesis, antitumour activity and mechanism of action. Pharm Weekbl Sci, 7, 173–180.
   PubMedGoogle Scholar
• Roller A, Weller M. (1998). Antioxidants specifically inhibit cisplatin cytotoxicity of human malignant glioma cells. Anticancer Res, 18, 4493–4497.
   PubMed Web of Science ®Google Scholar
• Salahudeen AK. (1995). Role of lipid peroxidation in H2O2-induced renal epithelial (LLC-PK1) cell injury. Am J Physiol, 268, F30–F38.
   PubMed Web of Science ®Google Scholar
• Saller R, Meier R, Brignoli R. (2001). The use of silymarin in the treatment of liver diseases. Drugs, 61, 2035–2063.
   PubMed Web of Science ®Google Scholar
• Sharma G, Singh RP, Chan DC, Agarwal R. (2003). Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. Anticancer Res, 23, 2649–2655.
   PubMed Web of Science ®Google Scholar
• Sonnenbichler J, Scalera F, Sonnenbichler I, Weyhenmeyer R. (1999). Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells. J Pharmacol Exp Ther, 290, 1375–1383.
   PubMed Web of Science ®Google Scholar
• Sonnenbichler J, Zetl I. (1986). Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers. Prog Clin Biol Res, 213, 319–331.
   PubMedGoogle Scholar
• Sung MJ, Kim DH, Jung YJ, Kang KP, Lee AS, Lee S, Kim W, Davaatseren M, Hwang JT, Kim HJ, Kim MS, Kwon DY, Park SK. (2008). Genistein protects the kidney from cisplatin-induced injury. Kidney Int, 74, 1538–1547.
   PubMed Web of Science ®Google Scholar
• Svobodová A, Walterová D, Psotová J. (2006). Influence of silymarin and its flavonolignans on H2O2-induced oxidative stress in human keratinocytes and mouse fibroblasts. Burns, 32, 973–979.
   PubMed Web of Science ®Google Scholar
• Valenzuela A, Aspillaga M, Vial S, Guerra R. (1989). Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Med, 55, 420–422.
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 39, 44–84.
   PubMed Web of Science ®Google Scholar
• Wang D, Lippard SJ. (2005). Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov, 4, 307–320.
   PubMed Web of Science ®Google Scholar
• Yang YS, Kwak IS, Nah HY, Kim YK. (2002). Role of hydroxyl radicals and lipid peroxidation in cisplatin-induced acute renal failure in rabbits. Korean J Nephrol, 21, 213–221.
   Google Scholar
• Zhong X, Zhu Y, Lu Q, Zhang J, Ge Z, Zheng S. (2006). Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway. Toxicology, 227, 211–216.
   PubMed Web of Science ®Google Scholar
• Zi X, Feyes DK, Agarwal R. (1998). Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. Clin Cancer Res, 4, 1055–1064.
   PubMed Web of Science ®Google Scholar